Eleusis And Silver Spike Acquisition Corp. II Mutually Agree To Terminate Business Combination Agreement
Eleusis, a clinical-stage life science company that aims to unlock the therapeutic potential of psychedelics, and Silver Spike Acquisition Corp. II (“Silver Spike II” or “SPKB”) (NASDAQ:SPKB), a